Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
APYX

Market Cap: $122.12M

AC

Apyx Medical Corporation

APYX

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin33.94%

EBITDA Margin-2.80%

EBIT Margin-4.09%

Pre-tax Margin-13.65%

Net Profit Margin-14.78%

Earnings Yield-7.06%

Valuation Multiples

Price / Book11.47

Price / Sales2.09

Price / Earnings-14.03

PEG-0.15

Forward PEG2.73

EV / Sales2.30

EV / EBITDA-81.94

EV / Operating Cash Flow-13.24

EV / Free Cash Flow-12.14

Price / Free Cash Flow-11.05

Price / Operating Cash Flow-12.07

Cash Flow & Capital

Free Cash Flow / Share-$0.26

Operating Cash Flow / Share-$0.24

Free Cash Flow Yield-9.05%

Capex / Revenue1.57%

Capex / Operating Cash Flow-9.08%

Capex / Depreciation1.17

Stock Compensation / Revenue3.23%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio5.68

Quick Ratio4.53

Cash Ratio2.95

Debt / Assets0.65

Debt / Capital0.79

Debt / Equity3.72

Long-Term Debt / Capital0.77

Debt / Market Cap28.93%

Net Debt / EBITDA-7.34

Solvency Ratio-0.16

Financial Leverage5.73

Efficiency & Working Capital

Asset Turnover0.96

Fixed Asset Turnover9.51

Inventory Turnover3.59

Receivables Turnover4.29

Payables Turnover17.62

Days Sales Outstanding85.07

Days Inventory Outstanding101.65

Days Payables Outstanding20.71

Operating Cycle186.72

Cash Conversion Cycle166.01

Working Capital Turnover1.31

Returns & Quality

Return on Equity-78.70%

Return on Assets-14.14%

Return on Invested Capital-6.78%

ROCE-6.84%

Return on Tangible Assets-14.14%

Operating Return on Assets-5.70%

Income Quality1.20

Tax Burden1.08

Interest Burden3.34

Balance Sheet & Intrinsic Metrics

Enterprise Value$134.13M

Invested Capital$49.94M

Working Capital$43.8M

Tangible Asset Value$11.09M

Net Current Asset Value$3.17M

Graham Net-Net-$0.16

Book Value / Share$0.26

Tangible Book Value / Share$0.26

Cash / Share$0.66

Financial Health Scores

Piotroski Score3

Altman Z-Score0.99

Revenue$58.42M

EBIT$-2.39M

Market Cap$122.12M

Working Capital$43.8M

Retained Earnings$-94.47M

Total Assets$61.07M

Total Liabilities$49.98M